Ignite Creation Date:
2024-05-06 @ 4:12 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04901195
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2021-05-20
Brief Title:
A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-20
First Submit QC Date:
May 20 2021
Study First Post Date:
2021-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL